Polianta LTD Sarepta Therapeutics, Inc. Transaction History

Polianta LTD

  • $213 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 19, 2023
BUY
$106.4 - $157.19 $840,560 - $1.24 Million
7,900 New
7,900 $904,000
Q4 2020

Jan 13, 2021
SELL
$125.56 - $178.74 $1.08 Million - $1.54 Million
-8,600 Closed
0 $0
Q3 2020

Oct 07, 2020
BUY
$127.12 - $172.34 $317,800 - $430,850
2,500 Added 40.98%
8,600 $1.21 Million
Q2 2020

Jul 09, 2020
BUY
$93.0 - $171.7 $567,300 - $1.05 Million
6,100 New
6,100 $978,000

Others Institutions Holding SRPT

# of Institutions
529
Shares Held
84.2M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Polianta LTD Portfolio

Follow Polianta LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

News

Stay updated on Polianta LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email